RGS17
Regulator of G-protein signaling 17
Also known as: RGS-17, RGS17_HUMAN, RGSZ2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UGC6
- Gene
- RGS17
- Ensembl
- ENSG00000091844
- Chromosome
- 6
- Canonical length
- 210 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
This gene encodes a member of the regulator of G-protein signaling family. This protein contains a conserved, 120 amino acid motif called the RGS domain and a cysteine-rich region. The protein attenuates the signaling activity of G-proteins by binding to activated, GTP-bound G alpha subunits and acting as a GTPase activating protein (GAP), increasing the rate of conversion of the GTP to GDP. This hydrolysis allows the G alpha subunits to bind G beta/gamma subunit heterodimers, forming inactive G-protein heterotrimers, thereby terminating the signal. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
210 residues, UniProt reviewed canonical sequence.
>Q9UGC6|RGS17
1 MRKRQQSQNE GTPAVSQAPG NQRPNNTCCF CWCCCCSCSC LTVRNEERGE NAGRPTHTTK
61 MESIQVLEEC QNPTAEEVLS WSQNFDKMMK APAGRNLFRE FLRTEYSEEN LLFWLACEDL
121 KKEQNKKVIE EKARMIYEDY ISILSPKEVS LDSRVREVIN RNLLDPNPHM YEDAQLQIYT
181 LMHRDSFPRF LNSQIYKSFV ESTAGSSSESLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RGS17 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 4 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 4 nTPM
- cerebral cortex: 2.4 nTPM
- thyroid gland: 2.2 nTPM
- basal ganglia: 2.1 nTPM
- hypothalamus: 2 nTPM
- amygdala: 1.5 nTPM
Single-cell type
- pancreatic islet cells: 188 nCPM
- other brain neurons: 178 nCPM
- esophageal apical cells: 148 nCPM
- brain inhibitory neurons: 143 nCPM
- medullary thymic epithelial cells: 125 nCPM
- oligodendrocyte progenitor cells: 111 nCPM
Immune cell
- basophil: 0.3 nTPM
- neutrophil: 0.1 nTPM
- NK-cell: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- cerebellum: 10 nTPM
- hypothalamus: 9.8 nTPM
- midbrain: 9.6 nTPM
- spinal cord: 7.7 nTPM
- basal ganglia: 7.2 nTPM
- amygdala: 6.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.64
- gnomAD pLI
- 0.27
- gnomAD missense Z
- 0.94
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- G protein-coupled receptor signaling pathway
- negative regulation of signal transduction
- response to amphetamine
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RGS17 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RGS17 as an antibody target. Whether an autoantibody or antibody against RGS17 could matter depends on whether native RGS17 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RGS17 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RGS17 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...